Zelira Therapeutics
Perth, AustraliaFounded 2014
About Zelira Therapeutics
Zelira Therapeutics is a clinical-stage pharmaceutical company developing evidence-based cannabinoid therapies for insomnia, chronic pain, and autism-related conditions.
Key Facts
- 1Advanced multiple cannabinoid drug candidates through clinical trials
- 2Holds patents on proprietary cannabinoid formulations for sleep and pain
Frequently Asked Questions
What conditions does Zelira target?
Zelira focuses on insomnia, chronic pain, and autism-related symptoms through clinical-stage cannabinoid therapies.
Is Zelira publicly traded?
Yes, Zelira trades on the ASX under the ticker ZLD.
More Cannabis Companies in Perth
ZLD Stock
View live price, chart & analysis
Products
- ZEL-101 insomnia treatment
- ZEL-201 autism therapy
- Cannabinoid formulations
Specialties
Clinical cannabinoid developmentEvidence-based cannabis medicine
Company Details
- Type
- Medical & Pharma
- Location
- Perth, Australia
- Founded
- 2014
- Publicly Traded
- Yes
- Ticker
- ASX:ZLD
Browse all Medical & Pharma
View more companies in this category
Related Companies
More in Australia
Althea Group
Melbourne \u2014 Medical & Pharma
Cann Group
Melbourne \u2014 Producer & Grower
ECS Botanics
Launceston \u2014 Producer & Grower
Cannatrek
Melbourne \u2014 Medical & Pharma